Floatz logo

Doxycycline

Skin Toxicity

Fundacion CRIS de Investigación para Vencer el CáncerSmall moleculePhase 2Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Skin Toxicity cohort.

Asset / SponsorPhaseRating
Irinotecan
Amgen
Phase 2B
PANITUMUMAB
Amgen
Phase 2B
Cetuximab
Sun Yat-sen University
Phase 2CCC
Crisaborole
Sun Yat-sen University
Phase 2CCC
Triamcinalone
Memorial Sloan Kettering Cancer Center
Phase 2CCC
Clindamycin
Memorial Sloan Kettering Cancer Center
Phase 2CCC

Same molecule, other indications

Doxycycline is also rated in:

lymphangioleiomyomatosisDormant
BB
Indicative ·
64 / 100
View asset →
tuberous sclerosisDormant
BB
Indicative ·
64 / 100
View asset →
Chronic Pelvic Pain SyndromeDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →